Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-11

Clinical Trial Update: Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating vedolizumab for chronic HIV infection in patients on antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vedolizumab (vedolizumab)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: HIV-infection/AIDS | Phase 2 | Status: UNKNOWN